Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$360K Sell
3,047
-62
-2% -$7.16K 0.04% 317
2026
Q1
$372K Buy
3,109
+914
+42% +$120K 0.05% 285
2025
Q4
$299K Sell
2,195
-435
-17% -$62.6K 0.04% 326
2025
Q3
$388K Buy
+2,630
New +$365K 0.06% 273
2023
Q2
Sell
-516
Closed -$54K 1666
2023
Q1
$54K Buy
516
+23
+5% +$2.4K ﹤0.01% 585
2022
Q4
$54.5K Sell
493
-335
-40% -$35.1K ﹤0.01% 584
2022
Q3
$72K Buy
828
+370
+81% +$33.6K 0.01% 491
2022
Q2
$36K Sell
458
-33
-7% -$2.73K ﹤0.01% 636
2022
Q1
$42K Buy
491
+144
+41% +$13.8K ﹤0.01% 581
2021
Q4
$42K Buy
347
+29
+9% +$3.6K ﹤0.01% 555
2021
Q3
$39K Buy
318
+6
+2% +$772 ﹤0.01% 530
2021
Q2
$37K Buy
312
+254
+438% +$29K ﹤0.01% 533
2021
Q1
$6K Buy
58
+42
+263% +$4.26K ﹤0.01% 885
2020
Q4
$2K Hold
16
﹤0.01% 1006
2020
Q3
$1K Sell
16
-40
-71% -$3.11K ﹤0.01% 1081
2020
Q2
$4K Buy
56
+40
+250% +$2.64K ﹤0.01% 800
2020
Q1
$1K Buy
+16
New +$1.26K ﹤0.01% 1008

Other funds holding XYL

Ellevest Inc's XYL Position: Q2 2026 in Review

Ellevest Inc reduced its Xylem (XYL) stake by 2% in Q2 2026, selling an estimated $7.16K and leaving 3,047 shares worth $360K. The position accounts for 0.04% of the portfolio, ranked #317.

Ellevest Inc first reported a position in XYL in Q1 2020 and has held it in 17 quarters since. The position peaked at $388K in Q3 2025. 1,100 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Ellevest Inc held 3,047 shares of Xylem worth $360K as of Q2 2026.
  • Ellevest Inc sold 62 Xylem shares in Q2 2026, an estimated $7.16K.
  • Xylem made up 0.04% of Ellevest Inc's portfolio in Q2 2026, its #317 holding.
  • Ellevest Inc first reported a position in Xylem in Q1 2020 and has held it in 17 quarters since.
  • Ellevest Inc's Xylem position peaked at $388K in Q3 2025.
  • 1,100 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Ellevest Inc's 13F filing for Q2 2026, filed 10 Aug 2026.